{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:41:40Z","timestamp":1792406500621,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014125","name":"Fujian Provincial Health Commission","doi-asserted-by":"publisher","award":["2023CXA051"],"award-info":[{"award-number":["2023CXA051"]}],"id":[{"id":"10.13039\/501100014125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013092","name":"Science and Technology Planning Project of Fuzhou","doi-asserted-by":"publisher","award":["2022-S-008"],"award-info":[{"award-number":["2022-S-008"]}],"id":[{"id":"10.13039\/501100013092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2024J01497"],"award-info":[{"award-number":["2024J01497"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.tranon.2026.103075","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:22:10Z","timestamp":1791861730000},"page":"103075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Aggressive features and immune landscape of macrotrabecular hepatocellular carcinoma"],"prefix":"10.1016","volume":"74","author":[{"given":"Lixia","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meidan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qionglan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8753-5886","authenticated-orcid":false,"given":"Lihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.103075_bib0001","first-page":"836","article-title":"The global burden of hepatocellular carcinoma: incidence, mortality, and survival","volume":"75","author":"Bray","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tranon.2026.103075_bib0002","first-page":"48","article-title":"Global epidemiology and current status of hepatocellular carcinoma: a review of recent trends","volume":"542","author":"Lee","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2026.103075_bib0003","first-page":"748","article-title":"Risk factors for hepatocellular carcinoma: the role of viral hepatitis, alcohol consumption, and non-alcoholic fatty liver disease","volume":"52","author":"Liu","year":"2022","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.tranon.2026.103075_bib0004","first-page":"1083","article-title":"Hepatitis B and C and their contributions to hepatocellular carcinoma: insights into molecular pathogenesis and therapies","volume":"29","author":"Zhang","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tranon.2026.103075_bib0005","first-page":"287","article-title":"Current treatment strategies for hepatocellular carcinoma: a review of therapeutic advances and future directions","volume":"148","author":"Wu","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.103075_bib0006","first-page":"1795","article-title":"Recent advances in the management of hepatocellular carcinoma","volume":"41","author":"Galle","year":"2021","journal-title":"Liver Int."},{"key":"10.1016\/j.tranon.2026.103075_bib0007","first-page":"801","article-title":"Recurrent hepatocellular carcinoma after liver transplantation: risk factors and prognostic evaluation","volume":"55","author":"Zhang","year":"2023","journal-title":"TransPlant Proc."},{"key":"10.1016\/j.tranon.2026.103075_bib0008","first-page":"30","article-title":"Challenges in the management of hepatocellular carcinoma: recurrence, late diagnosis, and therapeutic efficacy","volume":"8","author":"Li","year":"2022","journal-title":"J. Hepatol. Transl. Res."},{"key":"10.1016\/j.tranon.2026.103075_bib0009","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2147\/JHC.S364703","article-title":"Macrotrabecular-massive hepatocellular carcinoma: light and shadow in current knowledge: light and shadow in current knowledge","volume":"9","author":"Sessa","year":"2022","journal-title":"J. HepatoCell Carcinoma"},{"key":"10.1016\/j.tranon.2026.103075_bib0010","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.3390\/biomedicines11092582","article-title":"Advances in histological and molecular classification of hepatocellular carcinoma","volume":"11","author":"Choi","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.tranon.2026.103075_bib0011","first-page":"690","article-title":"Macrotrabecular hepatocellular carcinoma: clinicopathological characteristics and clinical outcomes","volume":"34","author":"Lin","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.tranon.2026.103075_bib0012","first-page":"267","article-title":"Molecular mechanisms of macrotrabecular hepatocellular carcinoma","volume":"40","author":"Zhang","year":"2020","journal-title":"Liver Int."},{"key":"10.1016\/j.tranon.2026.103075_bib0013","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.4103\/IJPM.IJPM_751_20","article-title":"An update on subtypes of hepatocellular carcinoma: from morphology to molecular","volume":"64","author":"Vyas","year":"2021","journal-title":"Indian J. Pathol. Microbiol."},{"key":"10.1016\/j.tranon.2026.103075_bib0014","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.32740","article-title":"The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma","volume":"77","author":"Donne","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.tranon.2026.103075_bib0015","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.3390\/ijms22115801","article-title":"Tumor Immune Microenvironment and Immunosuppressive therapy in hepatocellular carcinoma: a review","volume":"22","author":"Oura","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.103075_bib0016","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.3748\/wjg.v28.i27.3346","article-title":"Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy","volume":"28","author":"Zhang","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tranon.2026.103075_bib0017","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.3748\/wjg.v27.i22.2994","article-title":"Hepatocellular carcinoma in viral and autoimmune liver diseases: role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment","volume":"27","author":"Granito","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.tranon.2026.103075_bib0018","first-page":"1591","article-title":"The role of cytotoxic T lymphocytes in tumor immune response and clinical outcomes","volume":"148","author":"Li","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.103075_bib0019","first-page":"213","article-title":"Cytotoxic T lymphocytes infiltration and prognosis in hepatocellular carcinoma: a comprehensive review","volume":"13","author":"Zhang","year":"2021","journal-title":"Immunotherapy."},{"key":"10.1016\/j.tranon.2026.103075_bib0020","first-page":"1481","article-title":"Tumor-infiltrating cytotoxic T cells and their prognostic significance in hepatocellular carcinoma","volume":"146","author":"Zhang","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.tranon.2026.103075_bib0021","first-page":"252","article-title":"Prognostic implications of tumor-infiltrating cytotoxic T lymphocytes in various cancers","volume":"41","author":"Wang","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.103075_bib0022","first-page":"2269","article-title":"The role of B cells in the progression and prognosis of hepatocellular carcinoma: a systematic review","volume":"69","author":"Goh","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.tranon.2026.103075_bib0023","first-page":"401","article-title":"The immune microenvironment of hepatocellular carcinoma: a focus on B cells","volume":"13","author":"Wang","year":"2021","journal-title":"Immunotherapy"},{"key":"10.1016\/j.tranon.2026.103075_bib0024","first-page":"1020","article-title":"The functional diversity of B cells in the tumor microenvironment: implications for hepatocellular carcinoma","volume":"74","author":"Zhang","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tranon.2026.103075_bib0025","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200950","article-title":"Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma","volume":"94","author":"Fan","year":"2021","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.tranon.2026.103075_bib0026","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/hep.29762","article-title":"Macrotrabecular-massive hepatocellular carcinoma: a distinctive histological subtype with clinical relevance","volume":"68","author":"Ziol","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.tranon.2026.103075_bib0027","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0000000000001289","article-title":"Macrotrabecular hepatocellular carcinoma: an aggressive subtype of hepatocellular carcinoma","volume":"43","author":"Jeon","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103075_bib0028","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","article-title":"Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives","volume":"17","author":"Shen","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2026.103075_bib0029","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bbrc.2019.02.004","article-title":"PD-1 efficiently inhibits T cell activation even in the presence of co-stimulation through CD27 and GITR","volume":"511","author":"Mizuno","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.tranon.2026.103075_bib0030","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.3390\/ijms24076495","article-title":"Navigating through the PD-1\/PDL-1 landscape: a systematic review and meta -analysis of clinical outcomes in hepatocellular carcinoma and their influence on immunotherapy and tumor microenvironment","volume":"24","author":"Ailia","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.tranon.2026.103075_bib0031","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/cas.15756","article-title":"Activated CTLA-4-independent immunosuppression of Treg cells disturbs CTLA-4 blockade-mediated antitumor immunity","volume":"114","author":"Watanabe","year":"2023","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.tranon.2026.103075_bib0032","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","article-title":"Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial","volume":"23","author":"Yau","year":"2022","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.tranon.2026.103075_bib0033","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1200\/JCO.19.01307","article-title":"KEYNOTE-240 investigators. pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: a randomized, double-blind, phase iii trial","volume":"38","author":"Finn","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.tranon.2026.103075_bib0034","article-title":"Macrotrabecular-massive hepatocellular carcinoma: a case report","volume":"16","author":"R","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.tranon.2026.103075_bib0035","doi-asserted-by":"crossref","DOI":"10.1038\/srep15179","article-title":"Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis","volume":"5","author":"Shang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2026.103075_bib0036","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.18632\/aging.101918","article-title":"Epigenetic control of Foxp3 in intratumoral T-cells regulates growth of hepatocellular carcinoma","volume":"11","author":"Liu","year":"2019","journal-title":"Aging (Albany. NY)"},{"key":"10.1016\/j.tranon.2026.103075_bib0037","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41389-020-00283-x","article-title":"Nuclear FOXP3 inhibits tumor growth and induced apoptosis in hepatocellular carcinoma by targeting c-Myc","volume":"9","author":"Gong","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.tranon.2026.103075_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.154292","article-title":"FOXP3 and SQSTM1\/P62 correlate with prognosis and immune infiltration in hepatocellular carcinoma","volume":"242","author":"Liu","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.tranon.2026.103075_bib0039","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/imm.13520","article-title":"Human FOXP3 and tumour microenvironment","volume":"168","author":"Wang","year":"2023","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.tranon.2026.103075_bib0040","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","article-title":"Landscape of infiltrating t cells in liver cancer revealed by single-cell sequencing","volume":"169","author":"Zheng","year":"2017","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.tranon.2026.103075_bib0041","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2022.02.032","article-title":"T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma","volume":"77","author":"Barsch","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tranon.2026.103075_bib0042","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2020.4564","article-title":"Efficacy and safety of nivolumab plus ipilimumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib: the CheckMate 040 randomized clinical trial","volume":"6","author":"Yau","year":"2020","journal-title":"JAMa Oncol."},{"key":"10.1016\/j.tranon.2026.103075_bib0043","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","article-title":"Cancer genome atlas research network. comprehensive and integrative genomic characterization of hepatocellular carcinoma","volume":"169","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.tranon.2026.103075_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1431211","article-title":"Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy","volume":"15","author":"Du","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tranon.2026.103075_bib0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12943-020-01234-1","article-title":"Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2026.103075_bib0046","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s13402-023-00841-6","article-title":"Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma","volume":"46","author":"Chen","year":"2023","journal-title":"Cell Oncol. (Dordr)"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326004110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326004110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:52:20Z","timestamp":1792403540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326004110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":46,"alternative-id":["S1936523326004110"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103075","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aggressive features and immune landscape of macrotrabecular hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103075"}}